remote patient monitoring and hospital at home for covid-19biointellisense confidential cv slides...
TRANSCRIPT
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.
Remote Patient Monitoring and Hospital at Home for COVID-19
March 2020
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
COVID-19 CDC Guidelines: Active Monitoring• Active monitoring means that the state or local public
health authority assumes responsibility for establishing regular communication with potentially exposed people to assess for the presence of fever, cough, or difficulty breathing.
• For people with high-risk exposures, CDC recommends this communication occurs at least once each day.
• The mode of communication can be determined by the state or local public health authority and may include telephone calls or any electronic or internet-based means of communication.
2
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
COVID-19 CDC Guidelines: Quarantine and Isolation• Quarantine means the separation of a person or group of
people reasonably believed to have been exposed to a communicable disease but not yet symptomatic, from others who have not been so exposed, to prevent the possible spread of the communicable disease
• Isolation means the separation of a person or group of people known or reasonably believed to be infected with a communicable disease and potentially infectious from those who are not infected to prevent spread of the communicable disease. Isolation for public health purposes may be voluntary or compelled by federal, state, or local public health order.
3
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
In-Home Remote Patient Monitoring for COVID19• Elderly with complex chronic disease and other
immunocompromised patients (transplants, oncology, etc) are at high-risk for morbidity and mortality associated with COVID-19
• Continuous monitoring of vital signs and symptoms directlyassociated with COVID-19 may enable early detection and interventions that prevent exacerbation and hospitalization of this high-risk population especially those requiring Quarantine (COVID exposure) or Isolation (COVID confirmed)
• “Hospital at Home” via Remote Patient Monitoring (RPM) may enable earlier discharge of patients hospitalized with COVID-19 to expand bed capacity for new COVID-19 patients requiring admission
5
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |7
Effortless remote data collection
Medical gradeclinical accuracy
Minute to minute heart rate, respiratory rate, temperature, motion, symptoms, biometrics,
and more
Large on-board memory storage
Long lasting battery life (30+ days)
Cost effective continuous health
monitoring
‘Stick it on’ auto on-body detection
Bluetooth wireless data transmission
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
BioSticker Data Services - FDA 510k Cleared
8
SENSORS BIOSIGNALS BIOSIGNATURES
BIOSTICKER
Motion
AVS
TempSleep
Body Position
RespiratoryRate @ Rest
Skin Temperature
Walk/Run
Gait
Identity Management
Resting Heart Rate
Nocturia
Apnea Screen
Fall
Sneezing
Vomiting
Coughing
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
• Bluetooth enabled• Auto-detection of and communication with
BioSticker• Led touch screen and display• 5G Qualcomm cellular connectivity with
built-in ATT data plan• Captures data from multiple patients and
multiple BioSticker devices• Captures data from select third party blood
pressure meters and weight scales (others pending)
9
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
COVID – 19 Symptoms and Monitoring
10
RespiratoryRate @ Rest
Skin Temperature
Coughing
• FDA – cleared multi-parameter vital signs monitor
• Minute to minute temperature, respiratory rate, coughing tracker
• 30 – day continuous battery life• Bluetooth data transmission
• Stick it on and forget it’ auto on-body detection passive data capture ease of use
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
COVID – 19 Symptoms and Monitoring
11
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
COVID – 19 Remote Patient Monitoring
12
• RPM APPLICATIONS + DASHBOARDS• COMMAND CENTER SERVICES• HEALTH PROGRAMS & CARE PLANS
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
COVID – 19 Case Fatality by Age in China
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
RPM for COVID – 19 At – Risk Population
LEVEL 3
LEVEL 2
LEVEL 1
5% of Patients: Patients who meet High Risk criteria also requiring Quarantine (COVID exposure) or Isolation (COVID confirmed)
15% of Patients• Seniors with Complex Chronic Disease• Solid Organ Transplant Patients• Chemotherapy or BMT• Post Hospital Discharge from COVID
80% of Patients
EXTREME RISKPATIENTS
BIOSTICKER HOURLY MONITORING
HIGH RISK PATIENTS
BIOSTICKER TWICE DAILY MONITORING
LOW RISK
COVID-19 Mobile App Survey and Clinical Guidance Tool
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
BioIntelliSense COVID19 In-Home RPM
15
• High Risk Criteria:• Elderly (65+) with Complex Chronic Disease• Solid Organ and Bone-Marrow Transplant Patients• Cancer Patients Undergoing Chemotherapy
• Extreme Risk Criteria:• Patients requiring quarantine (COVID exposure) or isolation (COVID
confirmed) who meet High Risk criteria• Early Discharge “Hospital at Home”
• Early discharge of patients hospitalized with COVID-19 to expand bed capacity for new COVID-19 patients requiring admission
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
UC Health Virtual Care Command Center
16
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |
© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |18